Home › Funds › Revelation Capital Management, LLC › VRDN

Revelation Capital Management, LLC position in VRDN

OBSIDIAN THERAPEUTICS INC · Health Care

Revelation Capital Management, LLC reported holding 428,346 shares of VRDN (OBSIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 73.40% of its reported portfolio and ranking #1 among its reported holdings. Revelation Capital Management, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)428.35K sh
Reported value held$5.88M
Portfolio Weight73.40%
First reportedQ3 2026
Last changeNew
Updated2026-11-03

Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR

How Revelation Capital Management, LLC's VRDN position evolved

Revelation Capital Management, LLC first disclosed a stake in VRDN in Q3 2026 at 428,346 shares (US$5.9M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 428.35K $5.88M New

About VRDN and 13F data

VRDN (OBSIDIAN THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in VRDN — the largest reported positions include Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has Revelation Capital Management, LLC held VRDN?

Revelation Capital Management, LLC has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Revelation Capital Management, LLC's current position in VRDN?

As of Q3 2026, Revelation Capital Management, LLC holds 428.35K shares of VRDN (OBSIDIAN THERAPEUTICS INC), valued at $5.88M, representing 73.40% of its reported portfolio and ranking #1.

Has Revelation Capital Management, LLC been buying or selling VRDN?

In the latest 13F filing (Q3 2026), Revelation Capital Management, LLC newly opened its position in VRDN.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.